ARYA Sciences Acquisition Corp IV

ARYA Sciences Acquisition Corp IV (Nasdaq: ARYD), a blank-check company sponsored by Perceptive Advisors, focuses its acquisition mandate on the life sciences and biotechnology sector. The SPAC completed its initial public offering in 2021 and filed an 8-K with the Securities and Exchange Commission on February 28, 2024. Perceptive Advisors, a New York-based healthcare-focused investment manager, has backed multiple ARYA Sciences vehicles targeting therapeutics, diagnostics, and adjacent life sciences verticals. ARYD is among the later-vintage healthcare SPACs that remained active into 2024 as deal timelines extended across the broader blank-check market. For complete filing history, sponsor profiles, and deal analytics on ARYD and hundreds of other SPACs, sign up for full data access at SpacDesk.